Nrx Pharmaceuticals, INC. (NRXPW) — 10-K/A Filings

All 10-K/A filings from Nrx Pharmaceuticals, INC.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.

10-K/A Filings (2)

NRX Pharmaceuticals Files 2024 Annual Report Amendment — Apr 30, 2025 Risk: medium
NRX Pharmaceuticals, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Big Rock
NRX Pharmaceuticals Files Amendment to 2023 Annual Report — Apr 29, 2024 Risk: low
NRX Pharmaceuticals, Inc. (NRXPW) filed a Amended Annual Report (10-K/A) with the SEC on April 29, 2024. NRX Pharmaceuticals filed an amendment (10-K/A) to its

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX